Crispr Gene-Editing Therapy Safely Lowers Cholesterol and Triglycerides
Postedabout 2 months agoActiveabout 2 months ago
newsroom.clevelandclinic.orgResearchstory
calmmixed
Debate
20/100
Crispr Gene EditingCardiovascular HealthCholesterol Management
Key topics
Crispr Gene Editing
Cardiovascular Health
Cholesterol Management
Cleveland Clinic's first-in-human trial shows CRISPR gene-editing therapy safely lowers cholesterol and triglycerides, but commenters question the long-term benefits and effectiveness of related treatments.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
2h
Peak period
1
2-3h
Avg / period
1
Key moments
- 01Story posted
Nov 13, 2025 at 11:31 PM EST
about 2 months ago
Step 01 - 02First comment
Nov 14, 2025 at 1:35 AM EST
2h after posting
Step 02 - 03Peak activity
1 comments in 2-3h
Hottest window of the conversation
Step 03 - 04Latest activity
Nov 14, 2025 at 11:00 AM EST
about 2 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45923854Type: storyLast synced: 11/17/2025, 6:04:34 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Wow, that’s extremely counterintuitive based on everything I’ve heard from actual doctors (as opposed to influencers) about how great statins are and how rarely they result in real side effects (as opposed to nocebo effects).